Short Interest in P3 Health Partners Inc. (NASDAQ:PIII) Drops By 97.2%

P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 85,500 shares, a decline of 97.2% from the March 31st total of 3,080,000 shares. Based on an average daily trading volume, of 18,800 shares, the days-to-cover ratio is currently 4.5 days. Currently, 4.7% of the company's shares are short sold.

Analysts Set New Price Targets

Separately, Lake Street Capital cut their price objective on shares of P3 Health Partners from $50.00 to $20.00 and set a "buy" rating on the stock in a report on Monday, April 21st.

Institutional Investors Weigh In On P3 Health Partners

Several large investors have recently modified their holdings of PIII. Warberg Asset Management LLC increased its holdings in P3 Health Partners by 1,353.5% during the 4th quarter. Warberg Asset Management LLC now owns 145,346 shares of the company's stock worth $33,000 after purchasing an additional 135,346 shares in the last quarter. Sanders Morris Harris LLC raised its position in P3 Health Partners by 50.0% during the fourth quarter. Sanders Morris Harris LLC now owns 184,497 shares of the company's stock worth $41,000 after acquiring an additional 61,499 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of P3 Health Partners in the 4th quarter valued at about $46,000. Abundance Wealth Counselors lifted its position in shares of P3 Health Partners by 77.3% in the first quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock valued at $66,000 after buying an additional 174,395 shares during the last quarter. Finally, Wealthedge Investment Advisors LLC acquired a new stake in shares of P3 Health Partners during the 4th quarter worth about $83,000. 7.75% of the stock is currently owned by institutional investors.

P3 Health Partners Trading Down 5.9 %

Shares of P3 Health Partners stock traded down $0.56 during trading on Friday, hitting $8.94. 7,348 shares of the company were exchanged, compared to its average volume of 20,348. The firm has a market capitalization of $64.21 million, a P/E ratio of -10.64 and a beta of 0.96. The firm's fifty day moving average price is $9.07 and its 200 day moving average price is $11.62. The company has a debt-to-equity ratio of 1.11, a current ratio of 0.53 and a quick ratio of 0.53. P3 Health Partners has a 1-year low of $7.00 and a 1-year high of $40.50.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last issued its earnings results on Thursday, March 27th. The company reported ($16.00) EPS for the quarter, missing the consensus estimate of ($8.50) by ($7.50). The firm had revenue of $370.69 million during the quarter, compared to the consensus estimate of $378.88 million. P3 Health Partners had a negative net margin of 6.95% and a negative return on equity of 71.31%. As a group, sell-side analysts expect that P3 Health Partners will post -0.67 earnings per share for the current fiscal year.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.